Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Report 2017

With the slowdown in world economic growth, the Enzyme-Linked Immunosorbent Assay (ELISA) industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Enzyme-Linked Immunosorbent Assay (ELISA) market size to maintain the average annual growth rate of 0.94% from 175.00 million $ in 2013 to 180.00 million $ in 2016, Market analysts believe that the next few years, Enzyme-Linked Immunosorbent Assay (ELISA) market size will be further expanded, we expect that by 2021 , The market size of the Enzyme-Linked Immunosorbent Assay (ELISA) will reach 170 million $.

Section 1: Free——Definition

Section (2 3): 1200 USD——Manufacturer Detail (R&D Systems, Thermo Fisher Scientific , Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences, BioMérieux, EMD Millipore , BioLegend , LOEWE Biochemica, Mercodia, Cusabio, Shanghai Kehua Bio-engineering)

Section 4: 900 USD——Region Segmentation (United States, Canada, South America, China, Japan, India, Korea, Germany, UK, France, Italy, Europe, Middle East, Africa, GCC)

Section (5 6 7): 500 USD——Product Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, , ), Industry(Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantitation) and Channel (Direct Sales, Distributor) Segmentation

Section 8: 400 USD——Trend (2017-2021)

Section 9: 300 USD——Product Type Detail

Section 10: 700 USD——Downstream Consumer

Section 11: 200 USD——Cost Structure

Section 12: 500 USD——Conclusion